Stock Comparison
HLN vs NBIX
Haleon plc and Neurocrine Biosciences Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$43.55B
$15.19B
P/E (TTM)
20.2
21.8
Forward P/E
18.0
22.1
Price/Sales
3.9
4.5
Price/Book
2.0
4.1
EV/EBITDA
14.0
16.5
Dividend Yield
1.93%
—
Profitability
Net Margin
14.43%
21.55%
Operating Margin
21.32%
25.19%
Return on Equity
10.10%
22.10%
Return on Assets
5.08%
11.70%
Growth (YoY)
Revenue Growth
2.20%
39.50%
Earnings Growth
-4.50%
31.10%
Price & Risk
Beta
0.2
0.4
52-Week High
$11.12
$185.50
52-Week Low
$8.61
$123.10
Analyst Target
$11.99
$213.13
Compare HLN and NBIX your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.